Discount drug program requires drug companies to sell deeply discounted drugs to hospitals that serve high numbers of ...

Your local 340B hospitals and federally qualified health centers aren’t the villains in this story. They are the safety net.

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of 340B drugs without the perverse incentives perpetuated by the current ...

One reason libertarians don’t trust the government is because so many well-intentioned government programs end up either ...

Kansas’ Jerry Moran is part of a bipartisan group of U.S. senators working to reduce large hospital networks’ fraud and abuse ...

A program that started in the early nineties meant to help low-income patients, is at the forefront. But some worry that ...

A discount drug program is being abused by large hospital chains in Chicago leaving communities on the South and West sides ...

FAH rebuts Senate hearing claims, clarifying taxpaying hospitals do not benefit from the 340B drug pricing program discounts.

Vas Narasimhan confirmed that Novartis is having weekly discussions with the Trump administration on drug pricing, but a deal ...

A bipartisan group of senators is working to draft legislation to reform a fast-growing hospital drug discount program designed to help low-income patients.

If drugmakers have their way, the federal government likely ends up spending $100 billion of taxpayer funds to bail out rural hospitals.

The 340B program was established by Congress in 1992 to provide steep discounts to hospitals that serve a large proportion of ...